First, overexpression of STC2 improved hepatic steatosis and hypertriglyceridemia in obese mice [78]; here, we identified a rare variant (5:173,328,063:C:A) negatively associated with predicted PDFF and serum triglycerides. This evidence concerns the gene STC2 and fatty liver disease.